Maurice Zauderer

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Microbial Community

Saccharomyces Cerevisiae

Top Venues

Nature communications

Clinical and translational medicine

Nature medicine

Journal of neuroinflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Maurice Zauderer, Elizabeth Erin Evans
Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases. Clinical and translational medicine 13 (2) (2023)
Maurice Zauderer, Elizabeth Erin Evans
Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases. Clinical and translational medicine 13 (2) (2023)
Maurice Zauderer, Elizabeth Erin Evans
Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases. Clinical and translational medicine 13 (2) (2023)
Maurice Zauderer, Elizabeth Erin Evans
Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases. Clinical and translational medicine 13 (2) (2023)
Christoph Klenk, Maria Scrivens, Anina Niederer, Shuying Shi, Loretta Mueller, Elaine Gersz, Maurice Zauderer, Ernest S Smith, Ralf Strohner, Andreas Plückthun
A Vaccinia-based system for directed evolution of GPCRs in mammalian cells. Nature communications 14 (1) (2023)
Christoph Klenk, Maria Scrivens, Anina Niederer, Shuying Shi, Loretta Mueller, Elaine Gersz, Maurice Zauderer, Ernest S Smith, Ralf Strohner, Andreas Plückthun
A Vaccinia-based system for directed evolution of GPCRs in mammalian cells. Nature communications 14 (1) (2023)
Christoph Klenk, Maria Scrivens, Anina Niederer, Shuying Shi, Loretta Mueller, Elaine Gersz, Maurice Zauderer, Ernest S Smith, Ralf Strohner, Andreas Plückthun
A Vaccinia-based system for directed evolution of GPCRs in mammalian cells. Nature communications 14 (1) (2023)
Christoph Klenk, Maria Scrivens, Anina Niederer, Shuying Shi, Loretta Mueller, Elaine Gersz, Maurice Zauderer, Ernest S Smith, Ralf Strohner, Andreas Plückthun
A Vaccinia-based system for directed evolution of GPCRs in mammalian cells. Nature communications 14 (1) (2023)
Andrew Feigin, Elizabeth E Evans, Terrence L Fisher, John E Leonard, Ernest S Smith, Alisha Reader, Vikas Mishra, Richard Manber, Kimberly A Walters, Lisa Kowarski, David Oakes, Eric Siemers, Karl D Kieburtz, Maurice Zauderer, null null
Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial. Nature medicine (2022)
Andrew Feigin, Elizabeth E Evans, Terrence L Fisher, John E Leonard, Ernest S Smith, Alisha Reader, Vikas Mishra, Richard Manber, Kimberly A Walters, Lisa Kowarski, David Oakes, Eric Siemers, Karl D Kieburtz, Maurice Zauderer, null null
Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial. Nature medicine 28 (10) (2022)
Elizabeth E Evans, Vikas Mishra, Crystal Mallow, Elaine M Gersz, Leslie Balch, Alan Howell, Christine Reilly, Ernest S Smith, Terrence L Fisher, Maurice Zauderer
Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity. Journal of neuroinflammation 19 (1) (2022)